The effects of modafinil on striatal, pallidal and nigral GABA and glutamate release in the conscious rat: Evidence for a preferential inhibition of striato-pallidal GABA transmission

Neuroscience Letters

Volumn 253, Issue 2, 1998, Pages 135-138

  Ferraro, Luca ^a   Antonelli, Tiziana ^a   O'Connor, William T ^b   Tanganelli, Sergio ^a   Rambert, Francis A ^c   Fuxe, Kjell ^d  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c Neuropsychopharmacologie   (France)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

GABA; Globus pallidus; Glutamate; Microdialysis; Modafinil; Release; Striatum; Substantia nigra

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMIC ACID; MODAFINIL;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; CORPUS STRIATUM; GLOBUS PALLIDUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMALS; BENZHYDRYL COMPOUNDS; CORPUS STRIATUM; DOSE-RESPONSE RELATIONSHIP, DRUG; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; GLOBUS PALLIDUS; GLUTAMIC ACID; INJECTIONS, INTRAPERITONEAL; MALE; MICRODIALYSIS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; SYNAPTIC TRANSMISSION; TIME FACTORS; WAKEFULNESS;

EID: 0032483479     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00629-6     Document Type: Article

References (24)

1. Alam N.M., Szymusiak R., McGinty D. Local preoptic/anterior hypothalamic warming alters spontaneous and evoked neuronal activity in the magno-cellular basal forebrain. Brain Res. 696:1995;221-230.
2. Albin R.L., Aldridge J.W., Young A.B., Gilman S. Feline subthalamic nucleus neurons contain glutamate-like but not GABA-like or glycine-like immunoreactivity. Brain Res. 491:1989;185-188.
3. Alexander G.E., Crutcher M.D. Functional architecture of basal ganglia circuits, neural substrates of parallel processing. Trends Neurosci. 13:1990;266-271.
4. Akaoka H., Roussel B., Lin J.S., Chouvet G., Jouvet M. Effect of modafinil and amphetamine on the catecholaminergic neuron activity. Neurosci. Letts. 123:1991;20-22.
5. Chevalier G., Deniau J.M. Disinhibition as a basic process in the expression of striatal functions. Trends Neurosci. 13:1990;277-280.
6. De Sereville J.E., Boer C., Rambert F.A., Duteil J. Lack of pre-synaptic dopaminergic involvement in modafinil activity in anaesthetized mice: in vivo voltammetry studies. Neuropharmacology. 33:1994;755-761.
7. Duteil J., Rambert F.A., Pessonnier J., Hermant J.F., Gombert R., Assous E. Central alpha 1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil: studies with experimental animals. Eur. J. Pharmacol. 180:1990;49-58.
8. Ferraro L., Tanganelli S., O'Connor W.T., Antonelli T., Rambert F.A., Fuxe K. The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of local GABAergic mechanism. Eur. J. Pharmacol. 306:1996;33-39.
9. 3 receptor. Neurosci. Letts. 220:1996;5-8.
10. Ferraro L., Antonelli T., O'Connor W.T., Tanganelli S., Rambert F.A., Fuxe K. Modafinil: an antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers. Biol. Psychiatry. 42:1997;1181-1183.
11. Ferraro L., Antonelli T., O'Connor W.T., Tanganelli S., Rambert F.A., Fuxe K. The antinarcoleptic drug modafinil increases glutamate release in thalamic areas and hippocampus. NeuroReport. 8:1997;2883-2887.
12. Ferrè S., O'Connor W.T., Fuxe K., Ungerstedt U. The striato-pallidal neuron: a main locus for adenosine-dopamine interactions in the brain. J. Neurosci. 13:1993;5402-5406.
13. Fuxe K., Janson A.M., Rosen L., Finnman U.-B., Tanganelli S., Morari M., Goldstein M., Agnati L.F. Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis. Exp. Brain Res. 88:1992;117-130.
14. Fuxe K., Rambert F.A., Ferraro L., O'Connor W.T., Laurent P., Agnati L.F., Tanganelli S. Preclinical studies with modafinil. Evidence for vigilance enhancement and neuroprotection. Drugs Today. 32:1996;313-326.
15. Lin J., Sakai K., Vanni-Mercier G., Jouvet M. A critical role of the posterior hypothalamus in the mechanisms of wakefulness determined by microinjection of muscimol in freely moving cats. Brain Res. 479:1989;225-240.
16. Mignot E., Nishino S., Guilleminault C., Dement W.C. Modafinil binds to the dopamine uptake carrier site with low affinity. Sleep. 17:1994;436-437.
17. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1986.
18. Rambert F.A., Pessonnier J., Duteil J. Modafinil, amphetamine, and methylphenidate-induced hyperactivities in mice involve different mechanisms. Eur. J. Pharmacol. 183:1990;455-456.
19. er Cong. Francophone Sommeil, April 20-25, Jerba, 1992.
20. Sallanon M., Denoyer M., Kitahama K., Aubert C., Gay N., Jouvet M. Long-lasting insomnia induced by preoptic neuron lesions and its transient by muscimol injection into the posterior hypothalamus in the cat. Neurosci. 32:1989;669-683.
21. Simon P., Hemet C., Ramassamy C., Costentin J. Non-amphetaminic mechanism of stimulant locomotor effect of modafinil in mice. Eur. Neuropsychopharmacol. 5:1995;509-514.
22. Tanganelli S., Fuxe K., Ferraro L., Janson A.M., Bianchi C. Inhibitory effects of the psychoactive drug modafinil on gamma-aminobutyric acid outflow from the cerebral cortex of the awake freely moving guinea-pig. Possible involvement of 5-hydroxytryptamine mechanisms. Naunyn-Schmiedeberg's Arch. Pharmacol. 345:1992;461-465.
23. Touret M., Sallanon-Moulin M., Jouvet M. Awaking properties of modafinil without paradoxical sleep rebound: comparative study with amphetamine in the rat. Neurosci. Lett. 189:1995;43-46.
24. Vaugeois J.M., Pouhe D., Zuccaro F., Costentin J. Indirect dopamine agonists effects on despair test: dissociation from hyperactivity. Pharmacol. Biochem. Behav. 54:1996;235-239.